AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

MAYNE PHARMA GROUP LTD

3.200

+0.0200.63%

Volume:84.23K

Turnover:269.36K

Market Cap:259.99M

PE:-3.04

High:3.230

Open:3.210

Low:3.160

Close:3.180

52wk High:6.500

52wk Low:2.040

Shares:81.25M

Float Shares:67.00M

Volume Ratio:0.43

T/O Rate:0.13%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.051

EPS(LYR):-1.186

ROE:-20.58%

ROA:-2.30%

PB:0.74

PE(LYR):-2.70

Loading ...

Overview Company News Filings

Concept

Pharmaceutical Companies+2.85%

Capital Flow

Inflow:

Outflow:

News

Inhibitor Therapeutics Announces Annual Shareholder Meeting

Mayne Pharma Group Ltd-Non-Executive Director Appointment

THOMSON REUTERS

3 ASX Penny Stocks With Market Caps Under A$2B

Simply Wall St.

Australia's Mayne Pharma Falls on Lower Unaudited Revenue and Earnings

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrdive.com/stock/MYX.AU"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"MYX.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"MYX.AU\",,,,,undefined,":{"symbol":"MYX.AU","market":"AU","secType":"STK","nameCN":"MAYNE PHARMA GROUP LTD","latestPrice":3.2,"timestamp":1787638320000,"preClose":3.18,"halted":0,"volume":84234,"delay":0,"changeRate":0.0062893081761006345,"nameEN":"MAYNE PHARMA GROUP LTD","floatShares":66997185,"shares":81245827,"eps":-1.051059,"marketStatus":"Not Yet Opened","change":0.02,"latestTime":"08-25 16:12:00 AEST","open":3.21,"high":3.23,"low":3.16,"amount":269363,"amplitude":0.022013,"askPrice":3.21,"askSize":2575,"bidPrice":3.16,"bidSize":2683,"shortable":3,"etf":0,"ttmEps":-1.051059,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1787702400000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":3.18,"openAndCloseTimeList":[[1787616000000,1787637600000]],"volumeRatio":0.429931,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"MYX.AU","preClose":3.18,"auctionPrice":3.2,"auctionVolume":1542,"auction":3,"marketStatus":"盘后竞价","timestamp":1787638201378}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"MYX.AU\",,,,,undefined,":{"symbol":"MYX.AU","floatShares":66997185,"roa":"-2.30%","roe":"-20.58%","lyrEps":-1.185711,"volumeRatio":0.429931,"shares":81245827,"dividePrice":0,"high":3.23,"amplitude":0.022013,"preClose":3.18,"low":3.16,"week52Low":2.04,"pbRate":"0.74","psRate":"0.64","week52High":6.5,"institutionHeld":0,"latestPrice":3.2,"committee":0.02054,"eps":-1.051059,"divideRate":0,"volume":84234,"delay":0,"ttmEps":-1.051059,"open":3.21,"prevYearClose":3.11,"prevWeekClose":3.26,"prevMonthClose":2.66,"prevQuarterClose":2.79,"fiveDayClose":3.23,"twentyDayClose":2.62,"sixtyDayClose":2.33,"earningDate":1787760000000,"dividendPayoutRate":0.04569711225089115,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0.014818181818181815},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MYX.AU\",params:#limit:5,,,undefined,":[{"date":"2026-08-27","symbol":"MYX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787788800000,"name":null,"time":"","dateTimestamp":1787752800000,"actualEps":null},{"date":"2026-02-22","symbol":"MYX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1771714800000,"name":null,"time":"","dateTimestamp":1771678800000,"actualEps":null},{"date":"2025-08-29","symbol":"MYX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756425600000,"name":null,"time":"","dateTimestamp":1756389600000,"actualEps":null},{"date":"2025-02-26","symbol":"MYX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1740524400000,"name":null,"time":"","dateTimestamp":1740488400000,"actualEps":null},{"date":"2024-08-23","symbol":"MYX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724371200000,"name":null,"time":"","dateTimestamp":1724335200000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MYX.AU\",market:\"AU\",,,undefined,":[{"executeDate":"2023-01-18","recordDate":"2023-01-19","paymentDate":"2023-01-27","value":0.038,"currency":"AUD"}],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MYX.AU\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2660794482","title":"Inhibitor Therapeutics Announces Annual Shareholder Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2660794482","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660794482?lang=en_us&edition=fundamental","pubTime":"2026-08-17 20:02","pubTimestamp":1786968142,"startTime":"0","endTime":"0","summary":"Inhibitor Therapeutics announces annual shareholder meetingInhibitor Therapeutics schedules a virtual annual stockholder meeting on Sept. 15, 2026, held via the internet.Items include election of six ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nNDLBW5kx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","INTI","MYX.AU","BK7096","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657594604","title":"Mayne Pharma Group Ltd-Non-Executive Director Appointment","url":"https://stock-news.laohu8.com/highlight/detail?id=2657594604","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657594604?lang=en_us&edition=fundamental","pubTime":"2026-08-05 11:35","pubTimestamp":1785900920,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nTUE2LT2TP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7096","MYX.AU","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656581918","title":"3 ASX Penny Stocks With Market Caps Under A$2B","url":"https://stock-news.laohu8.com/highlight/detail?id=2656581918","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656581918?lang=en_us&edition=fundamental","pubTime":"2026-08-04 10:08","pubTimestamp":1785809324,"startTime":"0","endTime":"0","summary":"Australian shares are poised for a modest gain today, buoyed by a positive surge in U.S. equities, particularly from strong tech sector performances. For those looking beyond the major players, penny stocks—often smaller or newer companies—remain an intriguing area of investment despite being considered somewhat outdated as a term. In this article, we explore three penny stocks that combine robust financials with potential for significant growth, offering investors the chance to uncover...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/7131000-choice2-main-header/1585186813996","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/7131000-choice2-main-header/1585186813996"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/diversified-financials/asx-rpl/regal-partners-shares/news/3-asx-penny-stocks-with-market-caps-under-a2b-5","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/diversified-financials/asx-rpl/regal-partners-shares/news/3-asx-penny-stocks-with-market-caps-under-a2b-5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7096","SSM.AU","BK7062","BK7055","MYX.AU","RPL.AU","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655335608","title":"Australia's Mayne Pharma Falls on Lower Unaudited Revenue and Earnings","url":"https://stock-news.laohu8.com/highlight/detail?id=2655335608","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655335608?lang=en_us&edition=fundamental","pubTime":"2026-07-31 10:56","pubTimestamp":1785466577,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Mayne Pharma falls on lower unaudited revenue and earnings** Shares of Australia's Mayne Pharma GroupMYX.AXfall as much as 7.1% to A$2.415, marking their biggest intraday pct loss since March 19** Shares hit their lowest level since June 26** Specialty pharmaceutical copostsunaudited 4Q FY26 underlying EBITDA of A$4.6 million , down 76% from A$19.3 million last year** Posts unaudited 4Q FY26 revenue of A$86.5 million, down 22% from A$110.7 million in 4Q 2025** Co expects FY26 revenue to be A$383.7 million and underlying EBITDA to be A$31.7 million, down 6% and 33% on pcp, respectively** Nearly 259,300 shares change hands, about 1.3x the 30-day average** Stock down 19.3% YTD, including session's moves","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260731:nL4N43X09H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","BK7096","MYX.AU"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":13,"pageCount":1,"totalSize":52,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/MYX.AU\",params:#limit:6,delay:true,,,undefined,":[{"market":"AU","name":"Pharmaceutical Companies","id":"package_au_concept_yyswg","bkCode":"BK7508","changeRate":0.0285}]}}